%0 Journal Article
%T 吉非替尼对比培美曲塞联合顺铂治疗术后EGFR突变阳性Ⅱ~ⅢA期肺腺癌的临床分析<br>Clinical analysis of gefitinib versus pemetrexed combined with cisplatin in patients with stage Ⅱ-ⅢA lung adenocarcinoma harbouring positive EGFR mutations
%A 谢厚耐
%A 李猛
%A 许林
%A 王晖
%A 彭岳
%A 彭忠民&lt
%A br&gt
%A XIE Hounai
%A LI Meng
%A XU Lin
%A WANG Hui
%A PENG Yue
%A PENG Zhongmin
%J 山东大学学报（医学版）
%D 2018
%R 10.6040/j.issn.1671-7554.0.2018.419
%K 肺腺癌
%K 表皮生长因子受体突变
%K 培美曲塞
%K 辅助化疗
%K 吉非替尼
%K &lt
%K br&gt
%K Lung adenocarcinoma
%K Pemetrexed
%K Adjuvant chemotherapy
%K Gefitinib
%K Epidermal growth factor receptor mutation
%U http://yxbwk.njournal.sdu.edu.cn/CN/10.6040/j.issn.1671-7554.0.2018.419